|Videos|May 2, 2023

Interview with Jubilant’s President Chris Preti

Author(s)Jubilant

Key Learning Objectives:

  • Progress on previously announced $285 million expansion plan will double capacity for sterile injectables fill/finish at Jubilant HollisterStier’s Spokane, Wash. Facility
  • Strengthen’s Jubilant HollisterStier’s position in addressing contract manufacturing needs of major producers throughout North America
  • Jubilant HollisterStier is a leading contract manufacturer of sterile injectables, ophthalmics, optics, sterile and non-sterile topicals and liquids

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content